Analysis of Malaria Nucleic Acid Amplification Test Under the Temporary Permission in Malaria Blood Donation Restricted Area
10.17945/kjbt.2021.32.2.1 2 3
- Author:
JungWon KANG
1
;
JaeSook LEE
;
Dae Ho KO
;
Jae-won KANG
;
Yu Soek JUNG
;
Miae YOUN
Author Information
1. Korean Redcross Blood Transfusion Research Institute, Wonju, Korea
- Publication Type:Short Report
- From:Korean Journal of Blood Transfusion
2021;32(2):123-128
- CountryRepublic of Korea
- Language:English
-
Abstract:
There were 10 cases of transfusion-transmitted P. vivax malaria from 1990 to 2021. The Korean Centers for Disease Control and Prevention (KCDC) designated the areas showing a high frequency of malaria as a malaria-endemic area and has restricted whole blood donation from these areas. While the number of malaria infections has declined in recent years, the blood inventory has declined sharply due to the COVID-19 pandemic. Accordingly, the Ministry of Health and Welfare temporarily approved the donation of whole blood from malaria-endemic areas to secure the supply of blood products. In the present study, an anti-malaria screening and nucleic acid amplification test (NAT) was performed on samples collected from the malaria-endemic areas from May 20 to June 30, 2020. A total of 14,741 samples were collected and tested. NAT was performed for 1096 runs to test all the collected samples. The 117 (0.79%) samples showed initial reactive results due to the contamination of abnormal PCR results. Negative results were obtained for the samples showing initial reactive results using a duplicated re-test. From the NAT tests, no sample showed a true positive result. The results of the malaria antibody screening test were reactive in 10 out of the 14,741 samples. The malaria antibody screening needs to be reviewed through further study because of its insufficient sensitivity and specificity. According to this study, excluding the 10 reactive malaria antibodies, additional blood components could be secured from 14,731 blood donors for a stable blood supply.
